These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 4009086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
    Melis M.
    Rev Med Chil; 1984 Jan; 112(1):20-5. PubMed ID: 6377426
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of psoriasis with aromatic retinoid derivatives (Tigason) (double-blind method)].
    Gruca S, Jakubowicz K.
    Przegl Dermatol; 1984 Jan; 71(3):273-8. PubMed ID: 6395197
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H, Esca SA, Holubar K.
    Z Hautkr; 1980 Jan 15; 55(2):68-78. PubMed ID: 7405336
    [Abstract] [Full Text] [Related]

  • 7. Pilot study of a new retinoid, Ro 12-7554, in psoriasis and in some congenital disorders of keratinization.
    Ott F, Bounameaux Y.
    Dermatologica; 1983 Jan 15; 167(1):52-3. PubMed ID: 6226548
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double blind clinical trial of Tigason (Ro 10-9359) versus placebo in psoriasis.
    Jakubowicz K, Gruca S, Nowakowski H.
    Acta Univ Carol Med (Praha); 1986 Jan 15; 32(3-4):229-32. PubMed ID: 3324721
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E, Hidalgo H.
    Med Cutan Ibero Lat Am; 1983 Jan 15; 11(5):369-71. PubMed ID: 6230492
    [Abstract] [Full Text] [Related]

  • 12. Hyperkeratotic porokeratosis (Mibelli) with psoriasis--response to an aromatic retinoid.
    Beer WE, Smith NP.
    Clin Exp Dermatol; 1984 Sep 15; 9(5):509-13. PubMed ID: 6488582
    [No Abstract] [Full Text] [Related]

  • 13. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL, Mashkilleysson NA.
    Hautarzt; 1983 May 15; 34(5):229-30. PubMed ID: 6862887
    [Abstract] [Full Text] [Related]

  • 14. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N, Harnack K, Barth J, Heilmann S, Jäger K, Metz D, Schiller F.
    Z Hautkr; 1983 Sep 01; 58(17):1257-67. PubMed ID: 6636927
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The therapeutic efficacy of tigazon in treating dermatoses].
    Skripkin IuK, Korotkiĭ NG, Udzhukhu VIu, Kriazheva SS, Butov IuS.
    Vestn Dermatol Venerol; 1990 Sep 01; (5):4-6. PubMed ID: 2402940
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases.
    Christiansen JV, Holm P, Reymann F, Thestrup-Pedersen K.
    Dermatologica; 1984 Sep 01; 168(3):122-6. PubMed ID: 6714503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.